Skip to main content.
kumc.edu
Home

Kristin K. Grdinovac, M.D.

Kristine Grdinovac portrait
Associate Professor, Endocrinology, Diabetes and Clinical Pharmacology

Director of Cray Diabetes Self-Management Center, Director of Cray Diabetes Self-Management Center, Endocrinology, Diabetes and Clinical Pharmacology

Medical Director for Inpatient Diabetes, Diabetes Care Committee, Medical Director for Inpatient Diabetes, Diabetes Care Committee, Endocrinology, Diabetes and Clinical Pharmacology

Professional Background

Kristin Grdinovac, MD, is Associate Professor in the Department of Endocrinology, Diabetes, and Clinical Pharmacology at the University of Kansas Medical Center (KUMC).

Dr. Grdinovac earned a bachelors degree in Neuroscience and completed her pre-medicine curriculum at Vanderbilt University in Nashville, TN in 2007. She then returned to KUMC to complete medical school in 2011 and residency in Internal Medicine in 2015. She remained with the Internal Medicine Residency Program for an additional year as Chief Resident. Dr. Grdinovac then completed her Endocrinology fellowship at KUMC and remained as faculty in the Department of Endocrinology, Diabetes and Clinical Pharmacology in 2017. She was also appointed as Associate Director of Cray Diabetes Self-Management Center and Medical Director of Inpatient Diabetes in 2018. In 2022, she became the Director of the Cray Diabetes. She is passionate about academic medicine, diabetes management, and innovations in diabetes technology.

Dr. Grdinovac's research is focused on optimizing care delivery to patients with diabetes. In 2023, she created the Fresh Start Program, an intensive 24-week course combining medication optimization, diabetes education, and social support to improve outcomes in patients with uncontrolled diabetes. She continues to refine and expand the program with the long-term goal of making it a sustainable, reimbursable model of care that can be integrated into routine diabetes management. To further support equitable access to diabetes technology, Dr. Grdinovac and her team also launched the Cray CGM Assistance Program to help patients who are unable to afford continuous glucose monitoring devices.

Education and Training
  • BS, Neuroscience, Vanderbilt University, Nashville, TN
  • Residency, Internal Medicine, University of Kansas School of Medicine, Kansas City, KS
  • Residency, Internal Md, University of Kansas School of Medicine, Kansas City, KS
  • Clinical Fellowship, Endocrinology, University of Kansas Health System, Kansas City, KS
Licensure, Accreditations & Certifications
  • Internal Medicine, American Board of Internal Medicine
  • Endocrinology, Diabetes, and Metabolism, American Board of Internal Medicine
Professional Affiliations
  • Medical Knowledge Self Assessment Program 19 , MKSAP 19, Editor, 2019 - Present
  • American Diabetes Association, ADA, Member, 2017 - Present
  • American Association of Clinical Endocrinologists, AACE, Member, 2015 - Present
  • American Association of Clinical Endocrinologists - Heartland Chapter, AACE - Heartland Chapter, Member, 2014 - Present
  • The Endocrine Society, The Endocrine Society, Member, 2014 - Present
Current Research and Grants
  • Intensive Diabetes Intervention Program to Improve Outcomes for Patients with Type 2 Diabetes: The Fresh Start Program, Cray Medical Research Foundation, PI
  • Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults (PREVENTABLE), Duke University, Site-PI
  • Glycemic effects of intermittent fasting for patients with type 2 diabetes, IH NIGMS, Kansas Center for Metabolism and Obesity REsearch (KC-MORE) Research Project
  • Intermittent Fasting for the Treatment of Type 2 Diabetes., American Diabetes Association
  • A Study of Tirzepatide (LY3298176) Compared with Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CVOT), Eli Lily and Company
Selected Publications
  • Grdinovac, K, Alexander, E, Tilden, D, Rose, C, Robbins, D., C. 2023. Diabetes in Adults
  • Dunn, W, Song, X, Lowrance, M, Koestler, D, Grdinovak, K, Al-Hihi, E, Chen, GJ, Taylor, R, Wilson, J, Weinman, S. 2022. Patients with type 2 diabetes and elevated fibrosis-4 are Under-referred to Hepatology and Have Unrecognized Hepatic Decompensation. American Journal of Gastroenterology. https://doi.org/10.1111/jgh.15900
  • Wang, Ru, Miao, Zhugi, Liu, Tieming, Liu, Mei, Grdinovac, Kristin, Song, Xing, Liang, Ye, Delen, Dursun, Paiva, William. 2021. Derivation and Validation of Essential Predictors and Risk Index for Early Detection of Diabetic Retinopathy Using Electronic Health Records. Journal of Clinical Medicine. https://doi.org/10.3390/jcm10071473
  • Cristiano, Elizabeth., A., Harris, Ashley, Grdinovac, Kristin. 2022. Transient Central Diabetes Insipidus Occurring After Vasopressin Infusion. AACE Clinical Case Reports, 8 (1), 8-10. https://doi.org/10.1016/j.aace.2021.06.004
  • Cristiano, E, Grdinovac , K, Bhattacharya, R. 2021. Autoimmune Diabetes After Initiation of Nivolumab in a Patient With Hepatocellular Carcinoma. Journal of the Endocrine Society , 5 (Supplement 1). https://doi.org/10.1210/jendso/bvab048.752